Braviithi Technologies

Around 35% of diabetic patients suffered retinopathy, improved diagnostics and therapeutic strategies are needed to help these patients. Our technology facilitates, improves and supports the specialist decision and further referrals to ophthalmologist and diabeticians. Our mission is to accelerate breakthroughs for this approach by helping doctors leverage the ocular images to deepen understanding of disease biology and enhance the diagnostic. Our vision is to create unique patient profiles for an individualized standard of care, where patients experience faster and accurate diagnostics, fewer side effects and live longer. Braviithi is an innovation-driven image analysis company that focuses on the detection of diabetic retinopathy. At Braviithi we developed an innovative, automated, diabetic retinopathy diagnostic technology. We have been working on improving and master the product design and development since September 2015 and now we can introduce a completed and finished product which is not hungry on training data sets unlike other machine learning technologies which have voracious appetite for data to be optimized.